|
Featured Articles
|
|
How To Choose An Industrial Cation Exchanger For IgG Purification
By Pete Gagnon, Ph.D., chief scientific officer, Validated Biosystems
Cation-exchange chromatography is the third most used industrial method for antibody purification after anion-exchange and protein A affinity chromatography. It is most commonly used as an intermediate step, but continues to attract attention as a capture method.
|
|
|
Pharma Eyes PLM For Enterprise-Level Information To Handle FDA Compliance, PAT/QbD, Clinical Trials
By Peter A. Bilello, president, CIMdata Inc.
It may be impossible to find an industry facing more product development challenges than pharmaceuticals, not even oil and gas or nuclear power. In addition to the profitability, manpower, and sustainability issues that confront every enterprise, “pharma” managers wrestle daily with intense regulatory scrutiny, direct regulator involvement in operations, clinical trials, and long and costly development cycles.
|
|
|
|
Spotlight On Purification
|
|
Datasheet: Finn-Aqua Pure Steam Generator
The next generation Finn-Aqua Pure Steam Generator (PSG) offers the pharmaceutical industry unique features to enhance pure steam quality, reliability, safety, and cost-effectiveness.
|
|
|
MODcol® Multipacker® System And DAC Spring® Columns Datasheet
Whether using Davisil® or Vydac® (or other chromatographic media) the combined benefits of the MultiPacker® packing station and Spring® columns can deliver improved performance, productivity, and safety.
|
|
|
Single-Use Diaphragm Replacement Valve Datasheet
The ARTeSYN DRV is designed to be a drop in replacement for your existing diaphragm valves, but with an easy to remove and replace flow-through liner.
|
|
|
Lambda DNA Purification Kit Instruction Manual
Lambda DNA Purification Kit instructional manual covering materials, plating cultures, lysate preparation, purification of Lambda DNA, expected yields, quick reference protocols, troubleshooting, and reagent preparation.
|
|
|
|
Bulletin Board
|
|
New Bio-G Whitepaper: Capacity Planning In Biomanufacturing
Bio-G's new whitepaper, "Capacity Planning in Biomanufacturing" examines the key metrics involved in capacity decisions for biopharmaceutical operations. We demonstrate how to model demand as well as existing and new supply capacity in the 1- to 10-year planning horizon. Using simple models of risk and variability, we demonstrate how integrated ‘supply-demand’ models can be used to accurately predict and prepare manufacturing capacity for the pipeline. Download here.
|
|
|
|
|
|
|
